- ES
- EN
15th National Research Competition in Life and Earth Sciences
Rare diseases
Research Centre or Institution : Instituto de Biología y Genética Molecular. CSIC. Valladolid.
PSTPIP1 is involved in activation of the inflammasome, which generates the active form of IL 1beta. The mutations A230T and E250Q in PSTPIP1 cause the autoinflammatory disease known as PAPA. These mutations affect a region of this protein that interacts with the PTPPEST tyrosine phosphatase, blocking its interaction, which leads to increased phosphorylation of PSTPIP1. At present it is unknown what role tyrosine phosphorylation plays in regulating PSTPIP1 and what importance it can have for the function of this protein in inflammatory response. It is also unknown which stimuli and signalling pathways are involved in the phosphorylation of PSTPIP1. This project proposes to study the physiological function of PSTPIP1 in the inflammatory response and determine the molecular mechanisms by which PSTPIP1 intervenes in the pathogenesis of PAPA autoinflammatory disease.
Activities related
Projects related
News related
Publications related
International Symposium Understanding and reprogramming developmental visual disorders: from anophthalmia to cortical impairments Madrid, Thursday and Friday, 30 and 31 January 2020, 9:30 hours
Panel Discussion Mundo de las prótesis, los nuevos materiales, sus complicaciones y su futuro Madrid , Lunes, 8 de abril 2024. 17.00 horas
Session Situación actual de las Enfermedades Raras en España Madrid, Martes, 23 de abril de 2024, 10:00 horas


La Fundación Ramón Areces refuerza su compromiso con las enfermedades raras
Published on 04/23/2024